HIGHLIGHTS
- who: Prooksa Ananchuensook from the Division of Gastroenterology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Rama IV road, Pathumwan, Bangkok, Thailand have published the research work: Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization, in the Journal: (JOURNAL)
- what: This study demonstrated that the EZ-ALBI score, a simple liver reserve assessment, can stratify patients treated with TACE into distinct survival categories. Unlike the original Japanese cohort, which mainly comprised of patients with HCV infection (58.6%) , the patients in the study . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.